Refractive Surgery for the Glaucoma Suspect

J. Christian Hein; Jenna Tauber; Anurag Shrivastava

Disclosures

Curr Opin Ophthalmol. 2023;34(4):290-295. 

In This Article

Abstract and Introduction

Abstract

Purpose of Review: The aim of this study was to provide an update on perioperative considerations in the evaluation and management of patients undergoing primary corneal and intraocular refractive procedures who are at risk for progressive glaucomatous optic neuropathy.

Recent Findings: The necessity of a comprehensive baseline assessment prior to refractive procedures with structural and functional testing, along with documentation of preoperative intraocular pressure (IOP) measurements, is highlighted in recent literature. Substantiation of the increased risk of postoperative IOP elevation in keratorefractive procedures in patients with higher baseline IOP and lower baseline CCT, but not necessarily the degree of myopia, has been variably evidenced. Tonometry methods which are less influenced by postoperative corneal structural change should be considered in patients undergoing keratorefractive procedures. Vigilence in postoperative monitoring for progressive optic neuropathy is suggested given evidence of an increased risk of steroid-response glaucoma in these patients. Additional evidence for the IOP-lowering impact of cataract surgery in patients with an increased risk of glaucoma is provided, irrespective of intraocular lens choice.

Summary: Performing refractive procedures on patients at risk for glaucoma remains controversial. Definitive steps to optimize patient selection along with vigilance in disease state monitoring with longitudinal structural and functional testing can help mitigate potential adverse events.

Introduction

Although glaucoma is widely regarded as a relative contraindication to elective refractive procedures, specific guidelines for patient selection and management are not readily available. Given the subjective nature of diagnostic criteria, and the innate challenge of determining rates of disease progression without longitudinal data, refractive surgeons may be reluctant to operate on such patients. Although most refractive surgeons generally avoid keratorefractive procedures in patients with advanced disease and so on the decision to operate on patients earlier in the spectrum may be more subjective. In a 2008 survey of 100 glaucoma surgeons and 100 corneal refractive surgeons, 80% of glaucoma specialists indicated that they would recommend against laser-assisted in situ keratomileusis (LASIK) or photorefractive keratectomy (PRK) for patients diagnosed with glaucoma, while only 50% of cornea specialists would choose not to operate. However, for patients who were glaucoma suspects, two-thirds of glaucoma specialists and three-fourths of cornea specialists agreed that they would offer the procedure.[1] Further clarifications are additionally required to determine the risks, benefits, alternatives and postoperative considerations of refractive procedures such as refractive lens exchange with or without microinvasive glaucoma procedures (MIGS).

processing....